Combined treatment with ruxolitinib and MK-2206 inhibits the JAK2/STAT5 and PI3K/AKT pathways via apoptosis in MDA-MB-231 cellsEsin Güvenir Çelik, Onur Eroğlu|Research Square|2022Cited by 0